KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering

KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering

[at noodls] – SOUTH SAN FRANCISCO, CA (January 31, 2013): KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) today announced the pricing of its previously announced initial public offering of 8,750,000 shares of common stock … more

View todays social media effects on KBIO

View the latest stocks trending across Twitter. Click to view dashboard

See who KaloBios is hiring next, click here to view

Share this post